Ruby A. Escobedo

410 citations
12 papers · 85 indexed · h-index 7
Topics
SARS-CoV-2 and COVID-19 Research (3 papers)Influenza Virus Research Studies (3 papers)COVID-19 Clinical Research Studies (3 papers)

In The Last Decade

Ruby A. Escobedo

11 papers receiving 83 citations

Peers

Ruby A. Escobedo
Comparison fields: 5 of 31
  • Infectious Diseases 49
  • Epidemiology 39
  • Immunology 22
  • Molecular Biology 17
  • Surgery 10
Replace Journey Cole with:
Journey Cole United States
Patrick S. Creisher United States
Shannan Hall-Ursone United States
Alon Schneider Hait Denmark
Flonza Isa United States
Heng Long China
Gabrielle Lehmicke United States
Victoria Murray United States
Shah S. Hussain United States
Matthieu Perreau Switzerland
Ruby A. Escobedo relative to Journey Cole United States Journey Cole's profile →
Citations per field
00.5×2.8×
Journey Cole · 1×
Citations per year

Countries citing papers authored by Ruby A. Escobedo

Since Specialization
Citations

This map shows the geographic impact of Ruby A. Escobedo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruby A. Escobedo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruby A. Escobedo more than expected).

Fields of papers citing papers by Ruby A. Escobedo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruby A. Escobedo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruby A. Escobedo. The network helps show where Ruby A. Escobedo may publish in the future.

Co-authorship network of co-authors of Ruby A. Escobedo

This figure shows the co-authorship network connecting the top 25 collaborators of Ruby A. Escobedo. A scholar is included among the top collaborators of Ruby A. Escobedo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruby A. Escobedo. Ruby A. Escobedo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 0
2 2
3 2
4 2
5 8
6 16
7 11
8 4
9 12
10 6
11 16
12 6

About Ruby A. Escobedo

Ruby A. Escobedo is a scholar working on Biological Psychiatry, Infectious Diseases and Obstetrics and Gynecology, having authored 12 papers that have together received 85 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), Influenza Virus Research Studies (3 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Biological Psychiatry (8 citations), Infectious Diseases (49 citations) and Virology (8 citations). Ruby A. Escobedo has collaborated with scholars based in United States, Egypt and Mongolia. Frequent co-authors include Deepak Kaushal, Dhiraj Kumar Singh, Shashank Ganatra, Bindu Singh, Vinay Shivanna, Shabaana A. Khader, Smriti Mehra, Shannan Hall-Ursone, Xavier Álvarez and Riti Sharan. Their work appears in journals such as Journal of Clinical Investigation, Frontiers in Immunology and mBio.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026